SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

BRIEF-Cipla Enters Licensing Deal With Lilly To Expand Access To COVID-19 Treatment In India

05/09/2021 23:21
BRIEF-Cipla Enters Licensing Deal With Lilly To Expand Access To COVID-19 Treatment In India

- Cipla Ltd CIPL.NS:

  • ENTERS INTO A LICENSING AGREEMENT WITH LILLY TO EXPAND ACCESS TO COVID-19 TREATMENT IN INDIA

  • SIGNS DEAL WITH LILLY FOR MANUFACTURE, COMMERCIALIZATION OF BARICITINIB DRUG FOR COVID-19 INDICATION


Source text for Eikon: ID:nBSE8RYkZk

Further company coverage: CIPL.NS


(([email protected];))